Meet Barbara | See CAMZYOS PI at bit.ly/CAMZYOSpi

1 Views • 08/29/25

Side Effects

Subscribers

Please see Important Safety Information, including Boxed WARNING, and U.S. Full Prescribing Information at https://bit.ly/CAMZYOSpi and Medication Guide at https://bit.ly/CAMZYOSMedGuide.
Patients were compensated for their time.
Learn more about CAMZYOS at https://www.camzyos.com.

CAMZYOS® (mavacamten) is a prescription medicine used to treat adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM). CAMZYOS may improve your symptoms and your ability to be active. It is not known if CAMZYOS is safe and effective in children.

WARNING: RISK OF HEART FAILURE

CAMZYOS may cause serious side effects, including:
Heart failure, a condition where the heart cannot pump with enough force, is a serious condition that can lead to death. You must have echocardiograms before you take your first dose and during your treatment with CAMZYOS to help your healthcare provider understand how your heart is responding to CAMZYOS. People who develop a serious infection or irregular heartbeat have a greater risk of heart failure during treatment with CAMZYOS. Tell your healthcare provider or get medical help right away if you develop new or worsening shortness of breath, chest pain, fatigue, swelling in your legs, a racing sensation in your heart (palpitations), or rapid
weight gain.

The risk of heart failure is also increased when CAMZYOS is taken with certain other medicines. Tell your healthcare provider about the medicines you take, both prescribed and obtained over-the-counter, before and during treatment with CAMZYOS.

Because of the serious risk of heart failure, CAMZYOS is only available through a restricted program called the CAMZYOS Risk Evaluation and Mitigation Strategy (REMS) Program. Before you take CAMZYOS, you must enroll in the CAMZYOS REMS Program.

See full ISI at https://www.camzyos.com or click the icard in the video.

Barbara, who was told as a child she had a heart murmur, was used to living with symptoms such as occasionally becoming out of breath or feeling faint on a very hot day. This was her “normal,” so it didn’t occur to her to see a doctor about it. But one day when she was being prescreened for unrelated back surgery, she was diagnosed with symptomatic obstructive HCM. Barbara was put on a beta blocker at first, but her symptoms were still not improving. She was told that she would be a candidate for surgery, but by advocating for herself, she learned about a clinical trial. She was eligible to enroll, and after completion she learned she was receiving CAMZYOS.

For additional Important Safety Information, U.S. Full Prescribing Information, including Boxed WARNING visit https://bit.ly/CAMZYOSpi.

Learn more about CAMZYOS at https://www.camzyos.com.

Up next

Meet Barbara | See CAMZYOS PI at bit.ly/CAMZYOSpi

Up next

Please note that if you are under 18, you won't be able to access this site.

Up next

Meet Barbara | See CAMZYOS PI at bit.ly/CAMZYOSpi

Up next

Language